睡眠和昼夜时间对隐素系统的影响
Robin K Yuan1, Kirsi-Marja Zitting1
1Department of Medicine and Neurology, Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA.
Current sleep medicine reports
|September 11, 2025
概括
睡眠和昼夜节律显著影响隐素分泌,影响新陈代谢健康. 新兴研究探讨了用于睡眠障碍的GLP-1/GIP-RA药物,突出了代谢和睡眠医学的新前沿.
科学领域:
- 内分泌学 在内分泌学.
- 睡眠医学 睡眠医学
- 代谢健康 代谢健康
背景情况:
- 像GLP-1这样的胰岛素在新陈代谢调节中起着至关重要的作用.
- 睡眠和昼夜节律是已知的代谢结果的调节者.
- 隐形素,睡眠和昼夜节律之间的相互作用是新兴的研究领域.
研究的目的:
- 审查当前关于睡眠和昼夜因素如何影响隐素分泌的证据.
- 讨论GLP-1/GIP-RA药物在睡眠医学中的潜在临床应用.
- 确定这个跨学科领域的未来研究方向.
主要方法:
- 对现有文献进行系统审查.
- 分析了调查与睡眠和昼夜节律相关的隐素分泌的研究.
- 讨论临床试验数据和FDA批准的疗法.
主要成果:
- GLP-1的分泌遵循一个昼夜节律,这可能会被饮食,食时间和肠道微生物群扰乱.
- 睡眠不足和诸如肥胖和糖尿病之类的代谢状况,可以削弱或改变隐素分泌模式.
- 目前正在探索和批准GLP-1/GIP-RA药物,如蒂尔泽帕提德,用于治疗阻塞性睡眠呼吸暂停等与睡眠有关的疾病.
结论:
- 睡眠和昼夜节律显然会影响cretin系统.
- 需要进一步的研究来阐明复杂的相互作用,并优化治疗策略.
- 基于因克雷丁的疗法对同时管理代谢和睡眠障碍具有前景.
相关概念视频
Circadian Rhythms and Gene Regulation
4.5K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.5K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
354
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
354
Glucagon-like Receptor Agonists
854
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
854
Dipeptidyl Peptidase 4 Inhibitors
598
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
598
Management of Insomnia
543
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
543
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K


